Investigators explored the utility of unplanned resections, also called reresection, among patients who have soft tissue sarcomas. Experts have issued caution when considering reresection among ...

Socioeconomic and demographic factors impact surgical outcomes in upper extremity soft tissue sarcomas, affecting amputation ...

The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...

Predictive role of FAS for trabectedin in second lines of advanced soft tissue sarcoma (ASTS): A Spanish group for research on sarcoma (GEIS) study. This is an ASCO Meeting Abstract from the 2017 ASCO ...

Patients with soft tissue sarcomas showed improved functional results, quality of life and fewer side effects when treated with RT-therapy. Among patients with soft tissue sarcomas (STS), study ...

Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...

Please provide your email address to receive an email when new articles are posted on . The addition of pembrolizumab to radiation and surgery reduced relapse risk by 43%. Results showed no ...

Soft-tissue sarcomas are tumors that can happen in many different tissues in the body. Most soft-tissue sarcomas begin in the arms, legs, or the body wall. People usually first notice a painless lump, ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free survival, according to the results ...

Soft tissue sarcomas are a group of rare cancers that can occur in almost any part of the body and develop in tissues like muscle, fat, and nerves. The most common types are leiomyosarcoma, ...